13.58 USD
↘ 0.01 (0.07%)AT CLOSE (03:59 PM EDT)
Avalo Therapeutics, Inc. Common Stock
AVTXNASDAQ • USD
13.58
↘ 0.01 (0.04%)
POST MARKET (AS OF 04:55 PM EDT)
Post Market
AS OF 04:55 PM EDT
13.58
↘ 0.01 (0.04%)
Market: OPEN
Shares of Avalo Therapeutics, Inc. Common Stock (AVTX) are trading at $13.58. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. Notable factors include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. Valuation metrics place AVTX at a fair price relative to peers.
Technical & fundamental data as of Oct 7, 2026.
Open?$13.43
High?$13.98
Low?$13.30
Prev. Close?$13.59
Volume?719.0K
Avg. Volume?1.1M
VWAP?$13.72
Rel. Volume?0.67x
Bid / Ask
Bid?$11.66 × 100
Ask?$18.24 × 100
Spread?$6.58
Midpoint?$14.95
Valuation & Ratios
Market Cap?728.8M
Shares Out?53.6M
Float?48.6M
Float %?90.6%
P/E Ratio?N/A
P/B Ratio?1.62
EPS?-$1.87
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Avalo Therapeutics Inc is a clinical stage biotechnology company fully dedicated to developing IL-1B-based treatments for immune-mediated inflammatory diseases. The company's asset is Abdakibart (AVTX-009) an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalos pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein), AVTX-006 and AVTX-913.
Employees
33
Market Cap
728.8M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2015-11-13
Address
1500 LIBERTY RIDGE DRIVE
WAYNE, PA 19087
Phone: 410-522-8707
WAYNE, PA 19087
Phone: 410-522-8707
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?100
Momentum?50
Short Sent.?10
Piotroski F-Score?0/9Weak
Altman Z-Score?9.27Safe
Confidence?48%Low
Short InterestSqueeze Risk
Short % of Float?26.60%Squeeze Risk
Short Interest?12.9M
Days to Cover?13.2
Free Float48.6M
Avg Daily Volume976.4K
Settlement Date2026-09-15
Financial Health
Current Ratio?19.31Strong
Quick Ratio?19.31Strong
Cash Ratio?4.04Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?1.62CHEAP▾
Peers100
S&P84
P/S?12,353.08HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-7.1CHEAP▾
S&P97
EV/Sales?10,905.92HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?-22.4%WEAK▾
S&P7
ROA?-20.4%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-68290000
Enterprise Value?$643.4M
Fundamentals ratios updated end of day